Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07218640 · ClinicalTrials.gov registry record · NA

Aimmune Longitudinal Collaboration Study

A NA study of Stress and Dietary Fiber, sponsored by Aimmune Therapeutics.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
2
Study locations

NCT07218640: Recruiting NA study of Stress and Dietary Fiber, sponsored by Aimmune Therapeutics.

NCT07218640 is a NA study of Stress and Dietary Fiber that is actively recruiting participants, run by Aimmune Therapeutics. The registered enrollment target is 60 participants, below the 786-participant average among 152 other Stress trials with a reported enrollment target (92% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07218640, a NA study of Stress and Dietary Fiber, is actively recruiting participants, sponsored by Aimmune Therapeutics.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
2
Study locations

Study Summary

This study will include healthy households around the Irvine, CA area (based local to employees) and Tempe, AZ and Philadelphia, PA sites that will be instructed to take a daily fiber supplement (2.5 tablespoons of chia seeds \[\~10.3g of fiber\] which is one serving) for two months. Participants will use a stool sampling tool to facilitate ease of stool collection, or they may donate at a study site. Half of participants will add chia seeds to their diet at the beginning of the study and then return to their baseline diet for the second half of the study; half of participants maintain their baseline diet for the first half of the study and add chia seeds to their diet at the second half of the study as a cross-over design. Households (or individual participants, if their household is not participating) will be chosen at random to decide who implements the intervention in the first half versus the second half of the study. Data measurement including metabolomics and sequencing of stool samples, blood sampling for biobanking, stool IgA analysis, stress and diet evaluations will occur initially and throughout the study. Lifestyle questionnaires including but not limited to diet surveys, stress, or depression screening may be collected through electronic forms or telephonically. During enrollment, participants may be asked to complete questionnaires focused on medical, family, dietary, and social histories. At the end of the study, donor microbiota samples from individuals that are IgA low (undetectable) throughout the study will be evaluated from the presence of microbes that can degrade IgA. If investigators find this is the case, investigators will screen for microbes that can degrade IgA. For individuals that show persistent high fecal IgA or show a substantial improvement in IgA, investigators will transplant fecal samples or spores from fecal samples into germ-free mice to further understand the microbiome and pathophysiology relationship. For the latter, the in

Primary Outcome

Evaluate the impact of increased dietary fiber (an estimated additional 10 g per day) on stool SCFU (Spore Colony-Forming Units).

Interventions

  • OTHER Chia seeds

Study Locations (2)

Pennsylvania

  • Aimmune Therapeutics Manufacturing - Ambler
  • GoodNature Tempe - Ambler

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2025-10
Est. Completion 2026-07
Phase NA
Aimmune Therapeutics

10 total trials

What NCT07218640 shows while recruiting

NCT07218640 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 786-participant average among 152 other Stress trials with a reported enrollment target (92% lower).

The record links to 4 conditions, with Stress appearing as the primary indexed condition, and to 1 intervention - of which Chia seeds is the first listed.

NCT07218640 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT07218640 about?

NCT07218640 is a clinical study titled "Aimmune Longitudinal Collaboration Study". This study will include healthy households around the Irvine, CA area (based local to employees) and Tempe, AZ and Philadelphia, PA sites that will be instructed to take a daily fiber supplement (2.5 tablespoons of chia seeds \[\~10.3g of fiber\] which is one serving) for two months. Participants wi...

What is the current status of trial NCT07218640?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2025-10. Estimated completion is 2026-07.

What conditions does trial NCT07218640 study?

This clinical trial studies the following conditions: Stress, Dietary Fiber, Microbiome Composition, Stool Spore Colony Forming Units.

What interventions are being tested in trial NCT07218640?

The interventions under investigation include: Chia seeds (OTHER).

Who is sponsoring clinical trial NCT07218640?

This trial is sponsored by Aimmune Therapeutics, which has 10 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07218640 being conducted?

This trial has 2 study locations across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stress

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07218640's enrollment target sits among peer trials

60 91st of 152 higher than 57 of 152 other Stress trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Stress trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT07218640, the US trial registry maintained by the National Library of Medicine. NCT07218640 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.